Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIM11 antisense RNA 1 (TRIM11-AS1) is a long non-coding RNA transcribed antisense to the TRIM11 gene locus. There is extremely limited information regarding the biological functions, disease relevance, or therapeutic targeting of TRIM11-AS1 itself in the literature. All information in the retrieved search results pertains to TRIM11, a tripartite motif-containing protein involved in protein homeostasis, oncogenesis, and neurodegenerative disease[1][2][3][4]. No evidence supports direct targeting of TRIM11-AS1 as a therapeutic target or biomarker at this time[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRIM11 antisense RNA 1 (TRIM11-AS1).